Benefits of PANEXIATM Testing

The results of the PANEXIATM test enable the development of a patient-specific medical management plan to reduce the risk of cancer.  A positive result with PANEXIA may allow you to:

  • Target screening and surveillance specifically to individuals with a BRCA2 or PALB2 gene mutation
  • Improve patient and their family member’s compliance with tailored screening recommendations and preventive measures
  • Improve outcomes through prevention, earlier diagnosis and treatment of specific cancers, should they develop
  • Counsel patients and their family members on the underlying cause of mutation-related cancers in their family
  • Avoid unnecessary interventions for family members who do not test positive for the mutation known to be in the family